JCRRF
Price
$4.57
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
1.2B
SCLX
Price
$6.31
Change
-$0.16 (-2.47%)
Updated
Jun 6 closing price
Capitalization
165.55M
Interact to see
Advertisement

JCRRF vs SCLX

Header iconJCRRF vs SCLX Comparison
Open Charts JCRRF vs SCLXBanner chart's image
JCR PHARMACEUTICALS
Price$4.57
Change-$0.00 (-0.00%)
Volume$300
Capitalization1.2B
Scilex Holding
Price$6.31
Change-$0.16 (-2.47%)
Volume$159.31K
Capitalization165.55M
JCRRF vs SCLX Comparison Chart
Loading...
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JCRRF vs. SCLX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCRRF is a Hold and SCLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (JCRRF: $4.57 vs. SCLX: $6.31)
Brand notoriety: JCRRF and SCLX are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JCRRF: 119% vs. SCLX: 107%
Market capitalization -- JCRRF: $1.2B vs. SCLX: $165.55M
JCRRF [@Pharmaceuticals: Major] is valued at $1.2B. SCLX’s [@Pharmaceuticals: Major] market capitalization is $165.55M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JCRRF’s FA Score shows that 2 FA rating(s) are green whileSCLX’s FA Score has 0 green FA rating(s).

  • JCRRF’s FA Score: 2 green, 3 red.
  • SCLX’s FA Score: 0 green, 5 red.
According to our system of comparison, JCRRF is a better buy in the long-term than SCLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCLX’s TA Score shows that 4 TA indicator(s) are bullish.

  • SCLX’s TA Score: 4 bullish, 5 bearish.

Price Growth

JCRRF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SCLX (@Pharmaceuticals: Major) price change was +23.24% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.91%. For the same industry, the average monthly price growth was +5.75%, and the average quarterly price growth was +4.68%.

Reported Earning Dates

SCLX is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.91% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JCRRF($1.2B) has a higher market cap than SCLX($166M). JCRRF YTD gains are higher at: 0.000 vs. SCLX (-57.719). JCRRF has higher annual earnings (EBITDA): 7.45B vs. SCLX (-109.1M). JCRRF has more cash in the bank: 13.3B vs. SCLX (3.92M). SCLX has less debt than JCRRF: SCLX (128M) vs JCRRF (22.8B). JCRRF has higher revenues than SCLX: JCRRF (34.3B) vs SCLX (46.7M).
JCRRFSCLXJCRRF / SCLX
Capitalization1.2B166M721%
EBITDA7.45B-109.1M-6,831%
Gain YTD0.000-57.719-
P/E Ratio44.05N/A-
Revenue34.3B46.7M73,448%
Total Cash13.3B3.92M339,199%
Total Debt22.8B128M17,813%
TECHNICAL ANALYSIS
Technical Analysis
SCLX
RSI
ODDS (%)
Bearish Trend 1 day ago
39%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
44%
Momentum
ODDS (%)
Bullish Trend 1 day ago
42%
MACD
ODDS (%)
Bullish Trend 4 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
43%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
31%
Advances
ODDS (%)
Bullish Trend 3 days ago
69%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
37%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SCLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLERX14.030.05
+0.36%
GS Energy Infrastructure Fd R Shares
GSPIX40.46N/A
N/A
Goldman Sachs Large Cap Equity Instl
JLVZX19.85N/A
N/A
JPMorgan Large Cap Value R2
NELAX58.48N/A
N/A
Nuveen Equity Long/Short A
VIDMX9.97N/A
N/A
Virtus KAR Developing Markets I

JCRRF and

Correlation & Price change

A.I.dvisor tells us that JCRRF and SNYNF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCRRF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JCRRF
1D Price
Change %
JCRRF100%
N/A
SNYNF - JCRRF
8%
Poorly correlated
+1.65%
SCLX - JCRRF
4%
Poorly correlated
-2.47%
MIRA - JCRRF
2%
Poorly correlated
+2.19%
CSWYF - JCRRF
0%
Poorly correlated
N/A
VRBCF - JCRRF
-0%
Poorly correlated
N/A
More

SCLX and

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-2.47%
BIIB - SCLX
21%
Poorly correlated
+2.12%
AMRN - SCLX
20%
Poorly correlated
+7.34%
ABBV - SCLX
11%
Poorly correlated
+1.26%
RHHVF - SCLX
8%
Poorly correlated
+0.67%
NVS - SCLX
6%
Poorly correlated
+0.20%
More